OraSure Technologies, Inc. (“OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, announces the acquisition of Sherlock Biosciences, Inc., a global health company bringing next-generation diagnostics to consumers and healthcare providers. This acquisition expands OraSure’s innovation pipeline with the addition of Sherlock’s molecular diagnostics platform, which is able to provide rapid results with strong sensitivity and specificity in a disposable format that is well-suited for over-the-counter usage.
Read the full article: OraSure Technologies Acquires Sherlock Biosciences //
Source: https://www.globenewswire.com/news-release/2024/12/19/3000246/11732/en/OraSure-Technologies-Acquires-Sherlock-Biosciences.html